NEW YORK–(Business WIRE)–An affiliate of resources suggested by SK Cash Partners, LP (“SK Capital”) announced right now that it has arrived at an agreement to receive Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical firm that creates large-good quality, economical medications throughout all big therapeutic parts for people all over the world.
“Apotex is a dynamic, entrepreneurial corporation with a robust keep track of report of good results, underpinned by its diversified merchandise portfolio, strong pipeline of new launches and legendary model. We feel incredibly privileged to have the opportunity to guidance Apotex with our deep working experience in the pharmaceutical sector as it proceeds to investigate, produce and make secure and inexpensive medicines for sufferers in Canada, the United States and all around the planet,” said Aaron Davenport, Controlling Director at SK Capital.
Jeff Watson, President and CEO of Apotex, claimed, “We are fired up to work with SK Cash, whose market abilities and sources will enable grow our leadership in the marketplace and preserve our concentration on improving upon accessibility to higher-high quality cost-effective medications for millions of sufferers around the globe.”
Closing of the transaction is subject matter to the gratification of customary regulatory situations.
Direct arrangers RBC Funds Marketplaces, The Financial institution of Nova Scotia, HSBC and Truist Securities are providing dedicated funding in assist of the transaction. RBC Funds Markets, Scotiabank, Jefferies LLC and Deutsche Financial institution Securities Inc. served as monetary advisors to SK Cash and Kirkland & Ellis and McMillan LLP served as lawful counsel.
Rothschild & Co served as monetary advisor to Apotex and Davies Ward Phillips & Vineberg served as lawful counsel.
About SK Money
SK Money is a private expense business with a disciplined target on the specialty elements, specialty chemical substances, and prescription drugs sectors. The organization seeks to establish strong and developing companies that build significant long-term economic price. SK Money aims to benefit from its sector, working, and financial investment encounter to determine chances to remodel organizations into increased doing organizations with enhanced strategic positioning, progress, and profitability, as nicely as lower functioning threat. SK Capital’s portfolio of companies generates revenues of close to USD $16 billion on a yearly basis, employs far more than 20,000 men and women globally and operates 203 crops in 32 international locations. The organization presently has about USD $6.6 billion of property less than administration. For extra facts, remember to go to www.skcapitalpartners.com.
Apotex is a proudly Canadian, world pharmaceutical business that makes significant-top quality, very affordable medications for clients all over the world. Apotex employs just about 8,000 people today all over the world in manufacturing, R&D, and business functions. Apotex exports to extra than 100 international locations and territories and operates in a lot more than 45 nations around the world, with a considerable presence in Canada, the United States, Mexico, and India. For a lot more facts stop by: www.apotex.com.